Viatris Initiates Nationwide Recall of Xanax XR Over Dissolution Concerns
Overview of the Xanax XR Recall Viatris, Inc. has initiated a voluntary, nationwide recall of a specific batch of Xanax XR 3 mg extended-release tablets after discovering that the medication may fail to dissolve and release its active ingredients as intended. The recall, announced through the U.S. Food and Drug Administration (FDA), affects lot number…
